Skip to main content
. 2020 Jun 22;20:434. doi: 10.1186/s12879-020-05154-9

Table 2.

CT characteristics of three age groups of COVID-19 patients

Groups All patients (n = 307) Age < 40 Y (n = 104) 40 Y ≤ Age <60 Y (n = 137) 60 Y ≤ Age (n = 66) P1(G1 & G2) P2(G1 &G3) P3(G2 &G3)
CT Findings (LW)
 Location <0.001 <0.001 0.240
 One lobe or Two lobes 85 (27.7%) 58 (55.8%) 28 (20.4%) 9 (13.6%)
 Multiple lobes 222 (72.3%) 46 (44.2%) 109 (79.6%) 57 (86.4%)
 Number <0.001 <0.001 1.000
 One or two 31 (10.1%) 23 (22.1%) 5 (3.6%) 3 (4.5%)
 More 276 (89.9%) 81 (77.9%) 132 (96.4%) 63 (95.5%)
 Subpleural lesions 289 (94.1%) 90 (86.5%) 135 (98.5%) 64 (97%) <0.001 0.023 0.830
Shape
 pGGO 276 (89.9%) 99 (95.2%) 123 (89.8%) 54 (81.8%) 0.123 0.005 0.112
 mGGO 191 (62.2%) 60 (57.7%) 85 (62%) 46 (69.7%) 0.494 0.115 0.286
Sign
 Halo sign 254 (82.7%) 86 (82.7%) 114 (83.2%) 54 (81.8%) 0.915 0.884 0.806
 Reversed halo sign 38 (12.4%) 8 (7.7%) 22 (16.1%) 8 (12.1%) 0.051 0.335 0.459
 Crazy paving sign 117 (38.1%) 18 (17.3%) 66 (48.2%) 33 (50%) <0.001 <0.001 0.808
 Cavity sign 21 (6.8%) 3 (2.9%) 11 (8.3%)) 8 (12.1%) 0.091 0.039 0.348
Organizational involvement
 Vascular dilatation 249 (81.1%) 77 (74%) 112 (81.8%) 60 (90.9%) 0.053 0.002 0.089
 Bronchodilatation 146 (47.6%) 38 (36.5%) 69 (50.4%) 39 (59.1%) 0.032 0.004 0.243
CT Findings (MW)
 Pleural thickening* 36 (11.7%) 4 (3.8%) 21 (15.3%) 11 (16.7%) 0.004 0.004 0.806
 Pleural effusion* 15 (4.9%) 4 (3.8%) 6 (4.4%) 5 (7.6%) 1.000 0.480 0.541
 Lymphadenectasis 13 (4.2%) 3 (2.9%) 5 (3.6%) 5 (7.6%) 1.000 0.300 0.144

Note: G1 Age<40 Y, G2 40 Y ≤ Age<60 Y, G3 60 Y ≤ Age, LW lung window, MW mediastinal window, pGGO pure ground-glass opacity, mGGO mixed ground-glass opacity, * All but one patients had mild pleural thickening or a little effusion (the only one case had moderate pleural effusion)